Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew T. Wiley currently holds 359,036 shares of Foamix Pharmaceuticals Ltd. (FOMX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew T. Wiley has been a net seller of FOMX stock. They have purchased $50.5K and sold $116.4K worth of shares.
Matthew T. Wiley's most recent insider trade was on Sep 25, 2026, when they sold 3,097 shares at $36.57 per share.
Matthew T. Wiley serves as Executive at Foamix Pharmaceuticals Ltd. (FOMX). They have executed 36 insider transactions totaling $166.9K over their tenure at the company.
Matthew T. Wiley holds the position of Executive at Foamix Pharmaceuticals Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Matthew T. Wiley has shown a selling trading pattern, with $50.5K in total purchases and $116.4K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Matthew T. Wiley was on Sep 25, 2026, when they sold $113.3K worth of DFTX shares. This transaction involved 3,097 shares at $36.57 per share.
Matthew T. Wiley currently owns 359,036 shares of Foamix Pharmaceuticals Ltd. (FOMX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew T. Wiley's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew T. Wiley has 36 Form 4 filings on record as an insider at Foamix Pharmaceuticals Ltd..
Set alerts for Matthew T. Wiley and 40,000+ other insiders.